Quantcast

Latest Rosuvastatin Stories

2010-03-19 10:00:00

Highest approved dose of cholesterol-lowering medication could cause harm to muscles SILVER SPRING, Md., March 19 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today warned patients and healthcare providers about the potential for increased risk of muscle injury from the cholesterol-lowering medication Zocor (simvastatin) 80 mg. Although muscle injury (called myopathy) is a known side effect with all statins, today's warning highlights the greater risk of developing...

2010-03-02 07:30:00

OSAKA, Japan, ATLANTA and ANN ARBOR, Mich., March 2 /PRNewswire/ -- Shionogi & Co., Ltd. and QuatRx Pharmaceuticals Company, a privately-held pharmaceutical company, today announced that they have entered into a worldwide license agreement to develop and market ospemifene, a selective estrogen receptor modulator ("SERM"). Under the terms of this agreement, Shionogi will have worldwide marketing rights to ospemifene. QuatRx will receive an up-front payment of $25 million and is eligible...

2010-02-08 18:09:00

WILMINGTON, Del., Feb. 8 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced that the US Food and Drug Administration (FDA) has approved CRESTOR® (rosuvastatin calcium) to reduce the risk of stroke, myocardial infarction (heart attack) and arterial revascularization procedures in individuals without clinically evident coronary heart disease but with an increased risk of cardiovascular disease (CVD) based on age (men greater than or equal to 50 and women...

2009-12-15 16:58:00

WILMINGTON, Del., Dec. 15 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) today voted 12 yes, 4 no, and 1 abstention that AstraZeneca has established sufficient benefit to offset the observed risks to support the use of CRESTOR® (rosuvastatin calcium) in individuals meeting the following criteria: Men greater than or equal to 50 years, women greater than or equal to 60 years; Fasting LDL...

2009-12-11 10:32:00

WILMINGTON, Del., Dec. 11 /PRNewswire-FirstCall/ -- Today, the U.S. Food and Drug Administration (FDA) posted briefing materials in advance of the December 15(th) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) to discuss the supplemental New Drug Application (sNDA) filed by AstraZeneca (NYSE: AZN). The briefing materials can be found on the FDA web site. (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) In July, AstraZeneca announced that it had filed an...

2009-11-17 15:00:00

ORLANDO, Fla., Nov. 17 /PRNewswire/ -- A new analysis of 6,801 women in the JUPITER study showed CRESTOR® (rosuvastatin calcium) 20 mg significantly reduced cardiovascular (CV) events (defined as the combined risk of myocardial infarction, stroke, arterial revascularization, hospitalization for unstable angina, or death from CV causes) by nearly half (46 percent; p=0.002 vs. placebo) in women without cardiovascular disease (CVD), but at increased risk of a cardiovascular...

2009-11-09 05:28:00

NANJING, China, Nov. 9 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced an agreement to acquire the manufacturing license in China of Rosuvastatin from Tianjin Tianda Pharmaceutical Co., Ltd. ("Tianda"). The acquisition of the manufacturing license will be effected through the...

2009-10-16 07:00:00

WILMINGTON, Del., Oct. 16 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced the U.S. Food and Drug Administration (FDA) approved CRESTOR® (rosuvastatin calcium) for use in pediatric patients ages 10-17 with heterozygous familial hypercholesterolemia (HeFH) when diet therapy fails to reduce elevated cholesterol. HeFH, a genetic disease, is characterized by high LDL cholesterol (the "bad" cholesterol) and increased risk of early cardiovascular disease....

2009-09-01 07:00:00

WILMINGTON, Del., Sept. 1 /PRNewswire-FirstCall/ -- Recognizing that September is National Cholesterol Education Month (NCEM), AstraZeneca (NYSE: AZN) is urging all adults, especially the 98.6 million Americans over the age of 20 years old with high cholesterol (1), to talk to their doctors about elevated cholesterol and get their cholesterol levels checked. Elevated cholesterol can contribute to the buildup of plaque in the arteries, also known as atherosclerosis, which can begin in early...

2009-08-31 07:00:00

BARCELONA, Spain, Aug. 31 /PRNewswire/ -- A new analysis from the JUPITER study showed that CRESTOR((R)) (rosuvastatin calcium) 20mg reduced the composite primary end point of major cardiovascular (CV) events (myocardial infarction, stroke, arterial revascularization, hospitalization for unstable angina, or death from CV causes) by 39% (p<0.001), compared to placebo, in elderly patients with LDL-C less than 130 mg/dL and elevated high-sensitivity C-reactive protein (hsCRP). This analysis...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related